|
COX10 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.89251999999085E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.72163999999642E-05 |
| Normal-vs-Stage2 |
1.205790E-01 |
| Normal-vs-Stage3 |
5.296400E-01 |
| Normal-vs-Stage4 |
8.557800E-01 |
| Stage1-vs-Stage2 |
6.359800E-01 |
| Stage1-vs-Stage3 |
8.945800E-02 |
| Stage1-vs-Stage4 |
1.168210E-01 |
| Stage2-vs-Stage3 |
3.580400E-01 |
| Stage2-vs-Stage4 |
2.574000E-01 |
| Stage3-vs-Stage4 |
6.110400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.69740000000229E-05 |
| Normal-vs-AfricanAmerican |
1.370360E-02 |
| Normal-vs-Asian |
9.721600E-01 |
| Caucasian-vs-AfricanAmerican |
5.592800E-01 |
| Caucasian-vs-Asian |
3.813800E-01 |
| AfricanAmerican-vs-Asian |
4.189200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.82389999999955E-05 |
| Normal-vs-Female |
1.275690E-02 |
| Male-vs-Female |
6.154600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.181800E-01 |
| Normal-vs-Extreme_Weight |
5.379400E-03 |
| Normal-vs-Obese |
2.328400E-02 |
| Normal-vs-Extreme_Obese |
2.650000E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.672190E-01 |
| Normal_Weight-vs-Obese |
3.482800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.136900E-03 |
| Extreme_Weight-vs-Obese |
4.801000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.855900E-02 |
| Obese-vs-Extreme_Obese |
8.088400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.575570E-01 |
| Normal-vs-Age(41-60Yrs) |
4.49829999999984E-05 |
| Normal-vs-Age(61-80Yrs) |
5.611800E-04 |
| Normal-vs-Age(81-100Yrs) |
8.882200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.730800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.650400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.408200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.826400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.343700E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.323300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.66789999589412E-08 |
| Normal-VS-Type2 PRCC |
2.396400E-01 |
| Normal-VS-KIRP CIMP |
8.425600E-01 |
| Normal-VS-Unclassified PRCC |
3.347700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.768150E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.142000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.419800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.356800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.599380E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.072200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.236180E-01 |
| Normal-vs-N1 |
8.251000E-01 |
| Normal-vs-N2 |
2.01789999999535E-05 |
| N0-vs-N1 |
3.978000E-01 |
| N0-vs-N2 |
2.812200E-02 |
| N1-vs-N2 |
3.371800E-02 |
|
|
